OpenAlex 2,993 works 82 author topics
Works
2,993 works
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 100.0%
BACKGROUND: Blinatumomab, a bispecific monoclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts, was approved for use in patients with relapsed or refractory B-cell precursor ALL on the basis of single-group trials that showed ef…
-
OpenAlex top 1%
OpenAlex 100.0%
Brain and other central nervous system (CNS) tumors are among the most fatal cancers and account for substantial morbidity and mortality in the United States. Population-based data from the Central Brain Tumor Registry of the United States (a combined data set of the National Program of Cancer Registries [NPCR] and Su…
-
OpenAlex top 1%
OpenAlex 99.9%
Epidemiologists in the Brain Tumor Epidemiology Consortium (BTEC) have prioritized areas for further research. Although many risk factors have been examined over the past several decades, there are few consistent findings, possibly because of small sample sizes in individual studies and differences between studies in…
-
YÖKSİS
SJR Q2
JCR Q3
OpenAlex top 1%
OpenAlex 99.7%
Cisplatin and other platinum derivatives are the most widely used chemotherapeutic agents to treat solid tumors including ovarian, head and neck, and testicular germ cell tumors. A known complication of cisplatin administration is acute kidney injury (AKI). The nephrotoxic effect of cisplatin is cumulative and dose-de…
-
OpenAlex top 1%
OpenAlex 99.9%
BACKGROUND: Accurate childhood cancer burden data are crucial for resource planning and health policy prioritisation. Model-based estimates are necessary because cancer surveillance data are scarce or non-existent in many countries. Although global incidence and mortality estimates are available, there are no previous…
-
OpenAlex top 1%
OpenAlex 100.0%
BACKGROUND: In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 yea…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 98.9%
Allogeneic mobilized peripheral blood progenitor cells instead of bone marrow are increasingly used to restore hematopoiesis after myeloablative therapy. Data supporting this important change of clinical practice are scarce. We therefore assigned patients with early leukemias to peripheral blood or bone marrow transpl…
-
OpenAlex top 1%
OpenAlex 99.3%
Methotrexate, a folic acid antagonist, is used extensively not only for the treatment of cancer but also for the treatment of rheumatoid arthritis, psoriasis, and autoimmune disease and for the prevention of graft-versus-host disease after transplantation. The drug is also used as an abortifacient.1,2 Other folate ant…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 92.7%
Regarding the mechanisms of methotrexate (MTX) hepatotoxicity and nephrotoxicity, several hypotheses have been put forward, among which oxidative stress (including depletion of glutathione) is likely. This investigation elucidates the role of free radicals in MTX-induced toxicity and the protection by melatonin. Wista…
-
6585 Background: Functional screening of T-ALL cell lines for sensitivity to NOTCH inhibitors has led to the discovery of frequent NOTCH1 gain-of-function mutations in the majority of human T-ALL. Gamma secretase catalyzes the cleavage of the Notch receptor within the transmembrane domain thereby releasing the Notch i…
-
YÖKSİS
SJR Q2
JCR Q2
OpenAlex top 1%
OpenAlex 99.3%
No abstract yet.
-
YÖKSİS
SJR Q2
JCR Q2
OpenAlex top 1%
OpenAlex 99.3%
No abstract yet.
Academicians
82 academicians
- TÜLİN TIRAJE CELKAN 38 author topics
- SENİYE SEMA ANAK 32 author topics
- GÜNHAN GÜRMAN 28 author topics
- ÇETİN TİMUR 25 author topics
- ADALET MERAL GÜNEŞ 24 author topics
- ÖZDEN HATIRNAZ NG 21 author topics
- SERAP AKSOYLAR 18 author topics
- AYŞEGÜL ÜNÜVAR 17 author topics
- BÜLENT BARIŞ KUŞKONMAZ 16 author topics
- KORAY YALÇIN 14 author topics
- MELEK ERDEM 14 author topics
- PERVİN TOPÇUOĞLU 14 author topics